BR112013018938A2 - agente antifúngico tópico - Google Patents

agente antifúngico tópico

Info

Publication number
BR112013018938A2
BR112013018938A2 BR112013018938A BR112013018938A BR112013018938A2 BR 112013018938 A2 BR112013018938 A2 BR 112013018938A2 BR 112013018938 A BR112013018938 A BR 112013018938A BR 112013018938 A BR112013018938 A BR 112013018938A BR 112013018938 A2 BR112013018938 A2 BR 112013018938A2
Authority
BR
Brazil
Prior art keywords
antifungal agent
topical antifungal
agent
topical
pyrazol
Prior art date
Application number
BR112013018938A
Other languages
English (en)
Other versions
BR112013018938A8 (pt
BR112013018938B1 (pt
Inventor
Kaneda Kaori
Iida Maiko
Ohyama Makoto
Takahata Sho
Tabata Yuji
Original Assignee
Meiji Seika Pahrma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meiji Seika Pahrma Co Ltd filed Critical Meiji Seika Pahrma Co Ltd
Publication of BR112013018938A2 publication Critical patent/BR112013018938A2/pt
Publication of BR112013018938A8 publication Critical patent/BR112013018938A8/pt
Publication of BR112013018938B1 publication Critical patent/BR112013018938B1/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/36—Oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/18—One oxygen or sulfur atom
    • C07D231/20—One oxygen atom attached in position 3 or 5
    • C07D231/22—One oxygen atom attached in position 3 or 5 with aryl radicals attached to ring nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

resumo patente de invenção: "agente antifúngico tópico". a presente invenção refere-se a um agente anti-trichophyton que compreende, como ingrediente ativo, um composto tendo a estrutura de 2-(1h-pirazol-1-il)fenol representada pela fórmula (i) ou (ii) a seguir, ou um sal do mesmo. fórmula química 8
BR112013018938-0A 2011-01-30 2012-01-30 Composto antifúngico tópico, agente antifúngico para tinha e agente antifúngico para tinha das unhas BR112013018938B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2011017347 2011-01-30
JP2011-017347 2011-01-30
PCT/JP2012/051991 WO2012102404A1 (ja) 2011-01-30 2012-01-30 外用抗真菌剤

Publications (3)

Publication Number Publication Date
BR112013018938A2 true BR112013018938A2 (pt) 2017-10-17
BR112013018938A8 BR112013018938A8 (pt) 2018-01-09
BR112013018938B1 BR112013018938B1 (pt) 2019-10-08

Family

ID=46580967

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112013018938-0A BR112013018938B1 (pt) 2011-01-30 2012-01-30 Composto antifúngico tópico, agente antifúngico para tinha e agente antifúngico para tinha das unhas

Country Status (23)

Country Link
US (1) US8889727B2 (pt)
EP (1) EP2669274B1 (pt)
JP (1) JP5362128B2 (pt)
KR (1) KR101463707B1 (pt)
CN (1) CN103339112B (pt)
AR (1) AR084948A1 (pt)
AU (1) AU2012209696B2 (pt)
BR (1) BR112013018938B1 (pt)
CA (1) CA2825889C (pt)
CL (1) CL2013001995A1 (pt)
CO (1) CO6741178A2 (pt)
DK (1) DK2669274T3 (pt)
ES (1) ES2560930T3 (pt)
HK (1) HK1190713A1 (pt)
IL (1) IL227705A (pt)
MX (1) MX2013008777A (pt)
MY (1) MY161280A (pt)
RU (1) RU2593990C2 (pt)
SG (1) SG192582A1 (pt)
TW (1) TWI491593B (pt)
UA (1) UA110816C2 (pt)
WO (1) WO2012102404A1 (pt)
ZA (1) ZA201305718B (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150209301A1 (en) * 2012-07-30 2015-07-30 Nichiban Company Limited Patch for anti-dermatophytosis
JP6132842B2 (ja) * 2012-07-30 2017-05-24 Ｍｅｉｊｉ Ｓｅｉｋａファルマ株式会社 抗白癬菌症外用液剤
US8805865B2 (en) 2012-10-15 2014-08-12 Juked, Inc. Efficient matching of data
WO2014111871A1 (en) 2013-01-17 2014-07-24 Aurigene Discovery Technologies Limited 4,5-dihydroisoxazole derivatives as nampt inhibitors
EP3190105A4 (en) 2014-08-13 2018-05-30 Meiji Seika Pharma Co., Ltd. Crystalline anti-trichophyton drug and method for producing same
HRP20211604T1 (hr) 2016-03-15 2022-01-21 Igor Polyakov Kompozicije za liječenje i prevenciju bolesti kopita i kandži
US20210213002A1 (en) * 2017-10-30 2021-07-15 Kaken Pharmaceutical Co., Ltd. External preparation for treating trichophytosis unguium
CN110862349B (zh) * 2019-11-11 2023-05-05 南京医科大学 依达拉奉类似物及其制备方法和应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3628892A1 (de) * 1986-08-26 1988-03-10 Bayer Ag Substituierte 1-aryl-3-tert.-butyl-pyrazole
ES2015648A6 (es) 1989-05-05 1990-09-01 Consejo Superior Investigacion Procedeimiento de sintesis de mono y bis (3-r3-4-r4-5-r5-pirazol-1-il)1,4-dihidroxibencenos.
TW297813B (pt) * 1993-09-24 1997-02-11 Takeda Pharm Industry Co Ltd
DE4414897A1 (de) 1994-04-28 1995-11-02 Hoechst Ag Aromatische Diazoniumsalze und deren Verwendung in strahlungsempfindlichen Gemischen
JP3729884B2 (ja) 1995-01-05 2005-12-21 関東電化工業株式会社 フルオロフェノール類の製造方法
JPH1160528A (ja) 1997-08-12 1999-03-02 Ube Ind Ltd ４−クロロ−３−トリフルオロメチルフェノールの製法
AU2827100A (en) 2000-03-03 2001-09-17 Sumitomo Chemical Company, Limited Process for the preparation of phenylhydrazines
CA2453147A1 (en) 2001-07-11 2003-01-23 Boehringer Ingelheim Pharmaceuticals, Inc. Methods of treating cytokine mediated diseases
JP4537855B2 (ja) 2002-10-09 2010-09-08 久光製薬株式会社 抗真菌活性を有する新規ピラゾール化合物
KR100509603B1 (ko) 2002-12-28 2005-08-22 삼성에스디아이 주식회사 적색 발광 화합물 및 이를 채용한 유기 전계 발광 소자
US7977359B2 (en) 2005-11-04 2011-07-12 Amira Pharmaceuticals, Inc. 5-lipdxygenase-activating protein (FLAP) inhibitors
ATE510836T1 (de) 2006-01-19 2011-06-15 Matrix Lab Ltd Umwandlung eines aromatischen diazoniumsalzes in ein arylhydrazin
US20080119457A1 (en) * 2006-08-24 2008-05-22 Serenex, Inc. Benzene, Pyridine, and Pyridazine Derivatives

Also Published As

Publication number Publication date
EP2669274B1 (en) 2015-11-18
ZA201305718B (en) 2014-10-29
IL227705A0 (en) 2013-09-30
IL227705A (en) 2015-10-29
CA2825889A1 (en) 2012-08-02
KR20140008360A (ko) 2014-01-21
JPWO2012102404A1 (ja) 2014-07-03
CN103339112A (zh) 2013-10-02
NZ613856A (en) 2015-08-28
AU2012209696B2 (en) 2015-09-03
AU2012209696A1 (en) 2013-09-19
JP5362128B2 (ja) 2013-12-11
ES2560930T3 (es) 2016-02-23
US20130317074A1 (en) 2013-11-28
BR112013018938A8 (pt) 2018-01-09
SG192582A1 (en) 2013-09-30
UA110816C2 (uk) 2016-02-25
HK1190713A1 (zh) 2014-07-11
MY161280A (en) 2017-04-14
EP2669274A4 (en) 2014-07-16
KR101463707B1 (ko) 2014-11-19
CL2013001995A1 (es) 2013-11-22
RU2593990C2 (ru) 2016-08-10
TWI491593B (zh) 2015-07-11
EP2669274A1 (en) 2013-12-04
MX2013008777A (es) 2013-09-06
CO6741178A2 (es) 2013-08-30
RU2013140163A (ru) 2015-03-10
WO2012102404A1 (ja) 2012-08-02
DK2669274T3 (en) 2016-01-04
TW201309652A (zh) 2013-03-01
BR112013018938B1 (pt) 2019-10-08
CA2825889C (en) 2015-06-02
US8889727B2 (en) 2014-11-18
CN103339112B (zh) 2015-08-12
AR084948A1 (es) 2013-07-10

Similar Documents

Publication Publication Date Title
BR112013018938A2 (pt) agente antifúngico tópico
EA201500386A1 (ru) Пестицидные смеси, содержащие жасмоновую кислоту или её производное
BR112013025732A2 (pt) composto de imidazo-oxazina ou sal do mesmo
BR112014017749A8 (pt) Composto alquinilbenzeno 3,5-dissubstituído e sal do mesmo
BR112015032921A8 (pt) compostos de benzofuranila e benzoxazolila substituídos e utilizações dos mesmos
BR112015001121A2 (pt) composição para controle de doença de planta e aplicação para a mesma
BR112015018738A8 (pt) compostos de tetra-hidropirrolotiazina, seus usos, e composição farmacêutica
BR112015018966A2 (pt) composição de controle de pestes e uso da mesma
MX2020001453A (es) Compuestos de dihidroazol antiparasiticos y composiciones que comprenden los mismos.
BR112013021337A2 (pt) agente de controle de endoparasita e método para controlar endoparasitas
BR112013020270A2 (pt) derivados de pirazol microbicidas
BR112012027373A2 (pt) composição pesticida e seu uso
BR112015009806A2 (pt) composições adjuvantes aquosas
BR112014000178A2 (pt) composições tópicas
EA201270216A1 (ru) Фармацевтический состав
EA200901329A1 (ru) Применение пиридин-2-окси-3-карбонамидов в качестве защитных средств
BR112015010779A2 (pt) moduladores de di-hidropirazol gpr40
CO7180223A2 (es) Composición herbicida que tiene actividad herbicida mejorada
UA107709C2 (en) Microencapsulated oils for controlling pesticide spray drift
BR112012011002A2 (pt) derivado de 1-heterodieno e agente de controle de pragas
BR112014026198A2 (pt) compostos pirazol como inibidores de sglt1
BR112013028598A2 (pt) método para promover o crescimento de plantas
BR112015024075A2 (pt) compostos de piridinilpirazoloquinolina
BR112012021674A2 (pt) composição de controle de doença de planta e método para controlar doença de planta.
BR112014007078A2 (pt) composição de controle de doença de plantas e seu uso

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06T Formal requirements before examination [chapter 6.20 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 30/01/2012, OBSERVADAS AS CONDICOES LEGAIS. (CO) 20 (VINTE) ANOS CONTADOS A PARTIR DE 30/01/2012, OBSERVADAS AS CONDICOES LEGAIS

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 10A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2655 DE 23-11-2021 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.